Product Information

FLUOXETINE HCL 10 MG CAPSULE is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0339 per EA under NDC 82009010010. Its NADAC has been published 155 times since Nov 29, 2023.

FDA first approved this application on Jan 31, 2008. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FLUOXETINE HCL 10 MG CAPSULE

Fluoxetine Hydrochloride
$0.0339per EA

Strength

10 mg/1

NDC

82009010010

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

FLUOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078619

FDA Approved

1/31/2008

TE Code

AB1

On Market Since

9/1/2023

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for FLUOXETINE HCL 10 MG CAPSULE has been published 155 times since Nov 29, 2023, and over the history we have for it it has declined 7.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0339 per EA
All-time high$0.0371 (May 13, 2026)
All-time low$0.0283 (Nov 20, 2024)
52-week high$0.0371
52-week low$0.0315
Median price$0.0334
Average price$0.0334
Largest weekly change-17.2% (Nov 20, 2024)
Weeks tracked155
Tracking sinceNov 29, 2023

Price History

1W

0.0%

1M

-4.0%

3M

-5.4%

6M

-8.6%

1Y

+2.9%

3Y

N/A

5Y

N/A

All

-7.7%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FLUOXETINE HCL 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 10 MG CAPSULE, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0339 per EA (NDC 82009010010), effective Nov 11, 2026.

How has the price of FLUOXETINE HCL 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FLUOXETINE HCL 10 MG CAPSULE has declined 7.7%. It has been tracked across 155 weekly CMS publications since Nov 29, 2023.

What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 10 MG CAPSULE?

Since Nov 29, 2023, the NADAC for FLUOXETINE HCL 10 MG CAPSULE has ranged from a low of $0.0283 (Nov 20, 2024) to a high of $0.0371 (May 13, 2026), with a median of $0.0334 per EA.

Are there cheaper alternatives to FLUOXETINE HCL 10 MG CAPSULE?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUOXETINE HCL 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures FLUOXETINE HCL 10 MG CAPSULE?

FLUOXETINE HCL 10 MG CAPSULE (NDC 82009010010) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.